Singapore’s green revenue share in the STI reached 10.9% by end-2024, surpassing global averages and leading in sectors like ...

Salesforce plans to invest $1 billion in Singapore over the next five years as it seeks to fuel the adoption of its AI agent ...

US cloud software giant Salesforce said Wednesday it planned to invest $1.0 billion in Singapore over the next five years to ...

Please find enclosed copies of the Newspaper publication of Financial Results for the quarter and year ended 31st December 2024 of the Company published on 1st March 2025 in Business Standard and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sanofi licensed the antibody from Alopexx Pharmaceuticals, a precursor to the current biotech of the same name, in 2009 but faced challenges such as the slow enrollment (PDF) of a phase 2a trial.

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...

Considered and approved appointment of M/s BNP Associates and COmpany Company Secretaries as Secretarial Auditor for 5 years ...

The shares have sprung back to life thanks to China’s new stimulus programs—and Alibaba’s AI ventures. They stand to gain as much as 48%.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...